Professor, Internal Medicine, Mayo Medical School
Infectious Disease
Dr. Andrew D. Badley, MD
|
|
Give Review
Andrew Badley is an expert in the field of Infectious Disease. He received awards:"Elected Member". Dr. Andrew D. Badley has written publications. He has 101 publications published with PubMed. The lastest publication is: 'Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.' Dr. Andrew D. Badley is registered with Medicare and accepts Medicare payments.
Publications
- Prime, shock, and kill: Priming CD4 T cells from HIV patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size.
- Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation.
- CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.
- Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIV.
- Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice.
- HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
- Isolation of a TRAIL antagonist from the serum of HIV infected patients.
- The HIV-1 specific protein Casp8p41, induces death of infected cells through Bax/Bak.
- TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes.
- Human immunodeficiency virus envelope protein gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations.
- Intracellular Casp8p41 content is inversely associated with CD4 T cell count.
- How much gp120 is there?
- Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.
- Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis.
- HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum.
- The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases.
- HIV induces TRAIL sensitivity in hepatocytes.
- HIV gp120 induces, NF-kappaB dependent, HIV replication that requires procaspase 8.
- Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.
- HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice.
- Nelfinavir monotherapy increases naïve T-cell numbers in HIV-negative healthy young adults.
- Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication.
- Beneficial effect of TRAIL on HIV burden, without detectable immune consequences.
- Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.
- Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice.
- HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo.
- Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4.
- Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease.
- The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism.
- Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction.
- HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy.
- MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates.
- Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta.
- Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand.
- Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor.
- Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation.
- Ritonavir does not inhibit calpain in vitro.
- Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis.
- Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.
- Assessment of drug-drug interaction potential of enfuvirtide in human immunodeficiency virus type 1-infected patients.
- Production of CD8+ T cell nonlytic suppressive factors by CD28, CD38, and HLA-DR subpopulations.
- Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.
- Attenuated T-lymphocyte response to HIV therapy in individuals receiving HMG-CoA reductase inhibitors.
- Altering cell death pathways as an approach to cure HIV infection.
- Mechanisms of HIV-associated lymphocyte apoptosis: 2010.
- HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation.
- Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor.
- Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens.
- Modulation of apoptosis by HIV protease inhibitors.
- Flow cytometric measurement of telomere length.
- Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.
- The economic impact of cytomegalovirus infection after liver transplantation.
- Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number.
- Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy.
- Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.
- Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure.
- Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function.
- Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss.
- Modulation of HIV transcription by CD8(+) cells is mediated via multiple elements of the long terminal repeat.
- Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptions.
- Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression.
- Mechanisms of HIV-associated lymphocyte apoptosis.
- Noninvasive measurement of human ascending colon volume.
- 26-year-old man with HIV infection and abdominal pain.
- Infectious rates of central venous pressure catheters: comparison between newly placed catheters and those that have been changed.
- Relevance and risk factors of enterococcal bacteremia following liver transplantation.
- Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients.
- Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes.
- Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C.
- In vivo analysis of Fas/FasL interactions in HIV-infected patients.
- The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.
- Transcriptional regulation of the human FasL promoter-enhancer region.
- Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease.
- Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.
- Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Tr...
- Apoptosis in AIDS.
- Infective endocarditis caused by HACEK microorganisms.
- Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor.
- FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease.
- Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.
- Long-term follow-up of multifocal osteoarticular sporotrichosis treated with itraconazole.
- In vitro and in vivo effects of HIV protease inhibitors on apoptosis.
- Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.
- Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo.
- Cordyceps sinensis extracts do not prevent Fas-receptor and hydrogen peroxide-induced T-cell apoptosis.
- Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.
- Characteristics of hepatitis C virus infection in HIV-infected people.
- Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients.
- HIV-1 protease inhibitors and cytomegalovirus vMIA induce mitochondrial fragmentation without triggering apoptosis.
- Anti-apoptotic activity of the glutathione peroxidase homologue encoded by HIV-1.
- An electro-active system of immuno-assay (EASI assay) utilising self assembled monolayer modified electrodes.
- Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.
- Chemical composition and structure of food constituents: defining allergenic potential.
- A model of food-borne Listeria monocytogenes infection in the Sprague-Dawley rat using gastric inoculation: development and effect of gastric acidity on infective dose.
- Pathogenic marine vibrio species in selected Nova Scotian recreational coastal waters.
- Serological monitoring of epithelial ovarian cancer.
- Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease.
- A drug interaction between fusidic acid and a combination of ritonavir and saquinavir.
- Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir.
- Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10.
Schools
Dalhousie University Faculty Of Medicine
Dalhousie University
Mayo Clinic Rochester
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Elected Member
Education
-
Mayo School of Graduate Medical Education -
Dalhousie University Faculty of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1194799585 | |
| NPPES Provider LastName | BADLEY | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 30.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194799585 |
| Last Name Of The Provider | BADLEY |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
|
Dr. Odette C. El Helou, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark P. Wilhelm, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sana Arif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joyce L. Sanchez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron J. Tande, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seth J. Sullivan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pearlie P. Chong, MD |
|
|
Dr. Imad M. Tleyjeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sapna P. Sadarangani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dante P. Melendez Lecca, MD
This Doctor is OpenDoctor Recommended.
|